Skip to content
216.93 USD -0.24% -0.53
OPEN 215.96
DAY RANGE 218.48 - 214.48
52 WEEK RANGE 296.67 - 214.48
Interactive Brokers Logotype

Buy AMGN stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 115.9B
Enterprise value 145.9B
Trailing pe 14.74711
Forward pe 11.514331
Peg ratio 11.514331
Price to sales ttm 4.4257946
Price to book mrq 21.673494
Enterprise to revenue 5.573
Enterprise to ebitda 11.122


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.30229
Operating margin 0.36831
Return on assets ttm 0.081520006
Return on equity ttm 2.52778
Income statement
Revenue ttm 26.2B
Revenue per share ttm 48.999
Quarterly revenue growth -0.021
Gross profit ttm 19.9B
Ebitda 10.8B
Net income to common ttm 7.9B
Diluted eps ttm 14.71
Quarterly earnings growth yoy 0.925
Balance sheet
Total cash mrq 31.6B
Total cash per share mrq 59.067
Total debt mrq 61.6B
Total debt to equity mrq 1151.739
Current ratio mrq 3.145
Book value per share mrq 10.009
Cash flow
Operating cash flow ttm 8.6B
Levered free cash flow ttm 8B

Stock statistics

Shares outstanding 534.3M
Float shares 533.2M
Avg 10 volume 2.4M
Avg 30 volume 2.1M
Shares short 7.6M
Short ratio 4.06
Short percent of shares outstanding 0.014199999
Percent held by insiders 0.0021600001
Percent held by institutions 0.79827005

Stock price summary

Fifty two week low 214.48
Fifty two week high 296.67
Fifty two week change -18.352
Beta 0.641097
Day 50 ma 237.2996
Day 200 ma 249.8097

Dividends and splits

Forward annual dividend rate 8.52
Forward annual dividend yield 0.039300002
Trailing annual dividend rate 7.95
Trailing annual dividend yield 0.036558446
5 year average dividend yield 2.87
Payout ratio 0.5404
Dividend date 2023-06-08
Ex dividend date 2023-05-17
Last split factor 2-for-1 split
Last split date 1999-11-22

Amgen (AMGN) company profile

Amgen Inc. (NASDAQ: AMGN) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. The company also focuses on human therapeutics and innovating novel medicines based on cellular and molecular biology.